The influence of nonspecific immunotherapy on the course of Murine Melanoma
- 1 January 1977
- journal article
- research article
- Published by Wiley in Journal of Surgical Oncology
- Vol. 9 (1) , 15-20
- https://doi.org/10.1002/jso.2930090104
Abstract
BCG, Corynebacterium parvum, vitamin A, and levamisole were continuously administered to C57 BL/6 mice bearing B16 melanoma prior to, with, and following tumor implantation as well as before and coincident with surgical excision of the implanted tumor. Only the group given levamisole prophylactically for 8 weeks before tumor inplantation showed a significant difference from control mice but a tenfold increase in dosage in this drug did not exert a comparable effect.Keywords
This publication has 10 references indexed in Scilit:
- Effects of Levamisole on In Vivo and In Vitro Murine Host Response to Syngeneic Transplantable Tumor2JNCI Journal of the National Cancer Institute, 1975
- Growth and Immunogenicity of Murine B-16 Melanoma*Journal of Investigative Dermatology, 1974
- Malignant Melanoma: Specific Immunity Induced by Bacillus Calmette-Gurin in BALB/c MiceScience, 1974
- Levamisole inactive in treatment of four animal tumoursNature, 1974
- Active specific immunotherapy of minimal residual tumor: Excision plus neuraminidase-treated tumor cellsInternational Journal of Cancer, 1974
- Restoration of host defense mechanisms in man by levamisoleLife Sciences, 1973
- Drug-Induced Restoration of Cutaneous Delayed Hypersensitivity in Anergic Patients with CancerNew England Journal of Medicine, 1973
- Levamisole Inhibits and Cures a Solid Malignant Tumour and its Pulmonary Metastases in MiceNature New Biology, 1972
- Possibilities and Problems of Immunologic Intervention in CancerNew England Journal of Medicine, 1972
- Immunological Factors in Human Sarcomas and MelanomasAnnals of Surgery, 1970